|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:TGFBR3-SH3GLB1 (FusionGDB2 ID:89869) |
Fusion Gene Summary for TGFBR3-SH3GLB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: TGFBR3-SH3GLB1 | Fusion gene ID: 89869 | Hgene | Tgene | Gene symbol | TGFBR3 | SH3GLB1 | Gene ID | 7049 | 51100 |
Gene name | transforming growth factor beta receptor 3 | SH3 domain containing GRB2 like, endophilin B1 | |
Synonyms | BGCAN|betaglycan | Bif-1|CGI-61|PPP1R70|dJ612B15.2 | |
Cytomap | 1p22.1 | 1p22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | transforming growth factor beta receptor type 3TGF-beta receptor type 3TGF-beta receptor type IIITGFR-3betaglycan proteoglycantransforming growth factor beta receptor III | endophilin-B1Bax-interacting factor 1SH3 domain-containing GRB2-like protein B1SH3-containing protein SH3GLB1SH3-domain GRB2 like endophilin B1protein phosphatase 1, regulatory subunit 70testicular tissue protein Li 172 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000212355, ENST00000370399, ENST00000525962, ENST00000468996, | ENST00000370558, ENST00000535010, ENST00000482504, | |
Fusion gene scores | * DoF score | 14 X 13 X 6=1092 | 4 X 4 X 3=48 |
# samples | 15 | 4 | |
** MAII score | log2(15/1092*10)=-2.86393845042397 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TGFBR3 [Title/Abstract] AND SH3GLB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | TGFBR3(92262844)-SH3GLB1(87181407), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | TGFBR3-SH3GLB1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. TGFBR3-SH3GLB1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. TGFBR3-SH3GLB1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. TGFBR3-SH3GLB1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TGFBR3 | GO:0001837 | epithelial to mesenchymal transition | 18184661 |
Hgene | TGFBR3 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 12958365 |
Hgene | TGFBR3 | GO:0030509 | BMP signaling pathway | 18184661 |
Hgene | TGFBR3 | GO:0032354 | response to follicle-stimulating hormone | 14557487 |
Hgene | TGFBR3 | GO:0034695 | response to prostaglandin E | 14557487 |
Hgene | TGFBR3 | GO:0034699 | response to luteinizing hormone | 14557487 |
Hgene | TGFBR3 | GO:0051271 | negative regulation of cellular component movement | 17999987 |
Hgene | TGFBR3 | GO:0060317 | cardiac epithelial to mesenchymal transition | 18184661 |
Tgene | SH3GLB1 | GO:0031334 | positive regulation of protein complex assembly | 19074440 |
Fusion gene breakpoints across TGFBR3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SH3GLB1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-CD-8530-01A | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
Top |
Fusion Gene ORF analysis for TGFBR3-SH3GLB1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000212355 | ENST00000370558 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000212355 | ENST00000535010 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000212355 | ENST00000482504 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
Frame-shift | ENST00000370399 | ENST00000370558 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000370399 | ENST00000535010 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000370399 | ENST00000482504 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
In-frame | ENST00000525962 | ENST00000370558 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000525962 | ENST00000535010 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
5CDS-intron | ENST00000525962 | ENST00000482504 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
intron-3CDS | ENST00000468996 | ENST00000370558 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
intron-intron | ENST00000468996 | ENST00000535010 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
intron-intron | ENST00000468996 | ENST00000482504 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000525962 | TGFBR3 | chr1 | 92262844 | - | ENST00000370558 | SH3GLB1 | chr1 | 87181407 | + | 6283 | 308 | 62 | 1333 | 423 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000525962 | ENST00000370558 | TGFBR3 | chr1 | 92262844 | - | SH3GLB1 | chr1 | 87181407 | + | 0.000149418 | 0.9998505 |
Top |
Fusion Genomic Features for TGFBR3-SH3GLB1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
TGFBR3 | chr1 | 92262843 | - | SH3GLB1 | chr1 | 87181406 | + | 0.000333573 | 0.99966645 |
TGFBR3 | chr1 | 92262843 | - | SH3GLB1 | chr1 | 87181406 | + | 0.000333573 | 0.99966645 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TGFBR3-SH3GLB1 |
Go to FGviewer for the breakpoints of chr1:92262844-chr1:87181407 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000370558 | 0 | 9 | 155_195 | 24.0 | 366.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000482504 | 0 | 11 | 155_195 | 24.0 | 387.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000535010 | 0 | 8 | 155_195 | 0 | 266.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000370558 | 0 | 9 | 27_261 | 24.0 | 366.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000370558 | 0 | 9 | 305_365 | 24.0 | 366.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000482504 | 0 | 11 | 27_261 | 24.0 | 387.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000482504 | 0 | 11 | 305_365 | 24.0 | 387.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000535010 | 0 | 8 | 27_261 | 0 | 266.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000535010 | 0 | 8 | 305_365 | 0 | 266.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000535010 | 0 | 8 | 1_30 | 0 | 266.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000535010 | 0 | 8 | 1_37 | 0 | 266.0 | Region | Required for membrane binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000212355 | - | 3 | 17 | 455_730 | 82.0 | 852.0 | Domain | ZP |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000370399 | - | 4 | 18 | 455_730 | 82.0 | 851.0 | Domain | ZP |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000525962 | - | 2 | 16 | 455_730 | 82.0 | 852.0 | Domain | ZP |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000212355 | - | 3 | 17 | 21_787 | 82.0 | 852.0 | Topological domain | Extracellular |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000212355 | - | 3 | 17 | 810_851 | 82.0 | 852.0 | Topological domain | Cytoplasmic |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000370399 | - | 4 | 18 | 21_787 | 82.0 | 851.0 | Topological domain | Extracellular |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000370399 | - | 4 | 18 | 810_851 | 82.0 | 851.0 | Topological domain | Cytoplasmic |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000525962 | - | 2 | 16 | 21_787 | 82.0 | 852.0 | Topological domain | Extracellular |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000525962 | - | 2 | 16 | 810_851 | 82.0 | 852.0 | Topological domain | Cytoplasmic |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000212355 | - | 3 | 17 | 788_809 | 82.0 | 852.0 | Transmembrane | Helical |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000370399 | - | 4 | 18 | 788_809 | 82.0 | 851.0 | Transmembrane | Helical |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000525962 | - | 2 | 16 | 788_809 | 82.0 | 852.0 | Transmembrane | Helical |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000370558 | 0 | 9 | 1_30 | 24.0 | 366.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000370558 | 0 | 9 | 1_37 | 24.0 | 366.0 | Region | Required for membrane binding | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000482504 | 0 | 11 | 1_30 | 24.0 | 387.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:92262844 | chr1:87181407 | ENST00000482504 | 0 | 11 | 1_37 | 24.0 | 387.0 | Region | Required for membrane binding |
Top |
Fusion Gene Sequence for TGFBR3-SH3GLB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000525962_ENST00000370558_TCGA-CD-8530-01A_TGFBR3_chr1_92262844_-_SH3GLB1_chr1_87181407_length(transcript)=6283nt_BP=308nt GATTGTCTGTGCTCTGAGCAGGCTGAAGTGACTGGACGAGACGCACTGTTGGAGAAATAAAAATGACTTCCCATTATGTGATTGCCATCT TTGCCCTGATGAGCTCCTGTTTAGCCACTGCAGGTCCAGAGCCTGGTGCACTGTGTGAACTGTCACCTGTCAGTGCCTCCCATCCTGTCC AGGCCTTGATGGAGAGCTTCACTGTTTTGTCAGGCTGTGCCAGCAGAGGCACAACTGGGCTGCCACAGGAGGTGCATGTCCTGAATCTCC GCACTGCAGGCCAGGGGCCTGGCCAGCTACAGAGAGAGTTCACAGAAGAAAAGCTTGGCCAGGCTGAGAAGACAGAATTGGATGCTCACT TAGAGAACCTCCTTAGCAAAGCTGAATGTACCAAAATATGGACAGAAAAAATAATGAAACAAACTGAAGTGTTATTGCAGCCAAATCCAA ATGCCAGGATAGAAGAATTTGTTTATGAGAAACTGGATAGAAAAGCTCCAAGTCGTATAAACAACCCAGAACTTTTGGGACAATATATGA TTGATGCAGGGACTGAGTTTGGCCCAGGAACAGCTTATGGTAATGCCCTTATTAAATGTGGAGAAACCCAAAAAAGAATTGGAACAGCAG ACAGAGAACTGATTCAAACGTCAGCCTTAAATTTTCTTACTCCTTTAAGAAACTTTATAGAAGGAGATTACAAAACAATTGCTAAAGAAA GGAAACTATTGCAAAATAAGAGACTGGATTTGGATGCTGCAAAAACGAGACTAAAAAAGGCAAAAGCTGCAGAAACTAGAAATTCATCTG AACAGGAATTAAGAATAACTCAAAGTGAATTTGATCGTCAAGCAGAGATTACCAGACTTCTGCTAGAGGGAATCAGCAGTACACATGCCC ATCACCTTCGCTGTCTGAATGACTTTGTAGAAGCCCAGATGACTTACTATGCACAGTGTTACCAGTATATGTTGGACCTCCAGAAACAAC TGGGAAGTTTTCCATCCAATTATCTTAGTAACAACAATCAGACTTCTGTGACACCTGTACCATCAGTTTTACCAAATGCGATTGGTTCTT CTGCCATGGCTTCAACAAGTGGCCTAGTAATCACCTCTCCTTCCAACCTCAGTGACCTTAAGGAGTGTAGTGGCAGCAGAAAGGCCAGGG TTCTCTATGATTATGATGCAGCAAACAGTACTGAATTATCACTTCTGGCAGATGAGGTGATCACTGTGTTCAGTGTTGTTGGAATGGATT CAGACTGGCTAATGGGGGAAAGGGGAAACCAGAAGGGCAAGGTGCCAATTACCTACTTAGAACTGCTCAATTAAGTAGGTGGACTATGGA AAGGTTGCCCATCATGACTTTGTATTTATATACAATTAACTCTAAATAAAGCAGGTTAAGTATCTTCCATGTTAATGTGTTAAGAGACTG AAAATACCAGCCATCAGAAACTGGCCTTTCTGCCAATAAAGTTGCATGGTAAATATTTCATTACAGAATTTATGTTAGAGCTTTCATGCC AAGAATGTTTTCTTACAAAATTCTCTTTTTATTGAGGTTTCACTAATAAGCAGCTTCTACTTTTGAGCCTCAACTTAAAGCAGAACTGTT TTCTACTGGATTTTTCATTAACAGCAAGCTTTTTCTTTTATGTAAAATAAATCTATTGTGAATTGATATCAGCGACTCATTTATTAGGTA TAAATAATAGCCAAAGAATAAAATTAAAATTTATTTTAAACTTTCGGTCTTAAAAAGAGCTGTAGGATATAAACCTCTTTTGTGAAAAGT AGAATTTTCTGAATGCTTTCATAGACAAAAACGCATTTAAACTATGTTTACCTGGTTTTCCAACAGAAATCAAATGATTTTAATATTATG TTTTGATGGGTTATTTTCAGAGTTGTTTGGTTTTTTAAACACTACTGAATGGTTTCTTTTAAATTTAAGAACAACTAGTTCTTGAAAAGC AATACCGTATTTCTCTGATAAATTTGTAGTTAAGGTTCTAGAAAATCTAGGACAAATTTACTTCATTAAACATAAAGTTTTTAAGATTAT TCAGTTGGCACAATTTAATGCATAATTGGGATTGGATCCATTTACTGTACTGTGGTACAGTAAAGAGAATGTGTTCTTATTGAACAGCAG ATTTGTATACAAATACGGAATAATGCAACTACATTATAAATTGTATACGAACAAAATAAATTGGGTCACTCTGAGCTTACTATTAAAACA TTGAAAATTTATTAATGAACACAGGCTATCTTGATGAGGATCTCTGCTTATGAAACACATACTAATGAAATTATTAGTGACACATTGGAA GCTAGAAAATTGCTGTTGGGGCCATTGCTATAAATCATTGTTTCCATGTTAAGACTTCTGTTCTAATTCATTCATTCAACAAACATTTGT TGAGGGCCAGATACTGTGCTGGTCAACTGGGGATACTGTCCTGAACAATATGCACACAGTTCTTGCCCCTGCAGAGCTTAAAGACCATTA AAGGATACAGAAAATTAAGCAATTATCCTATAGTAGGATTCGTGGTGTGATGGGGAAAATACAAGGTACTGTATTTGGGAGTCATGTAAC TCCAGTTTTGGGAGTGAGAGAGGGTCTGGGGAAGAACTGTTCCAGATAAAAAGATGTGTAACCAAGATAGCATAGCACATTCTGACAACT AAAGCAATTTACTCTAACTTAAGCATGAAGTACAAAAGTATAGTTCATTTATTGAGGGAATGTTAAGCTATTAAAATGATACTTTTTGGT ACTTTTAAAAAAATGAATACTTAAACACCGTTTTAAAATTTTGTGTTAAGAGCTCCTAATAAGAACTTGGTAAACATGTTGACAATTTAA CTCACAGTCTAAACTTTAAAAGTAGTAGTTACCCTTTTATTTCTGTGCCATGAGACAAATTCTTCTGCAGTTTTATAGTTGTACAAGATG TTTTGACTCACTCTCAATTGCCATATTCTTAAAGAAACCCTGAAAAGCTGCTCAAGCTGGTCAGTTTTCTGTAAAACCAAGTAAATGAAA TTTTCTCTCCCCTCAGAAAGGAAGTTCTACAGCCTAGAGTACCATCTATTGTGTTTTATAAGTCCAGATTTAGGCTTTGAAAGATCATAC CAAAACTTCAGATCGACTTAAACAGCAACTATGAATTAGGTTTATGGGAAATGTAGTAATACAGGGGAAAGAATATCGGTAATGGAGTGA AATGGTCCTGGGTTCAAATCCAGTCTTCCTCACATATTGTGCTCTTTAAGCTTCAAATGAGATGTATAACTGCCTTTTCCTTACCAGTAA AATGAGGACAATAATTATGACACCATAGGGTGGTTGTGAGGATTAGCAAATGTTATCTTGTATTTCAGGTGCCTTTCAGGGAAAGGCTTG GCACATAGTAAACACATCCTGTAAATATCAGTTTCCCCTTGTTAGCCCCTGTAGCATCCTGACCTACCAAGTCTATAGGCCTTGCATATC ACTGTGCACCAGAGATACCTCTTTTACATCTGGGCTCTGTTTTCTCTCTATCAATCCTATCCTCCACCCTCTTTAAATCAGACCCCAGGT TTAACCTTCCCACAGTCAGTATAAATCATTTTTCAGAACTTTCAGCTTTCCATCAAGTGAAAGTTGATTTTAGTTACCCAGTAATGTACA GAAACCTTCAATAATGTTAAGCTTCAAAGGCTTCTGGTACGTTTGTCTACCACAGAACCACCACAATATATATGCTTGTTCTTAGGTTTA TTGCTTTTTATTTTAATGGGGTTTGGTTGTTTGGGTTTTATTTTGGTTTTGGCTTATTTTAAAGTCAAGTTTAGTTTTTACTCAGGTAAA GGCCTGAAGTTTCTTGGGCGTGGAAGAAAAAGCTTGGGAAGCCTATTAATTCATGGTGCAGTTCAGAATTGTTTAAATAAGCTCTGTGCC ACTGAGCTTAATCTGAAAGTATAGTGACATGTGAAGGATGCACATATGAATGAAAAACTAAAATAATTGTAGGCTCTTCTATAAATGAAA AAAAAAGTGATTGGATTGTGTCTACCTTTTTCCTCAAAGTAATCTAACCTAAACGGTCATGGTGTTAAAACTTTTTATGGTGCTAATCAG AAAAATTGATGTTGCAAGAAATGAGGTCTCAAAAATGGGAATGTGCCTCCTCACTCTGCGTCACATGGGAAATAAATCCTGAGGCCAGGA TCACCAGTGGGGTAGAGTCATCTTCATAGTCTCCTGTTATCCTCCCCCTGAACAAAGAACAAAGTGAGACTGGGAAGCTAGTGTTGGGGA AACATTTCTGGGATAAACTGTGGAGTGGAGAAGACAATGGAGGGCAAGGCAAAAACCCACAGACTTGTTTACCCATAGAGGCCCCACTCA CCTCCATGCTGACAGAATTCCAGAAAAATTCCTTCCCTATCTCCCAAACACCTGAAATTCTGAAATATTGCCCTACTATTTAGCACTTTA AGCTTCAGTGAGGTGCTGTAATGGAGAGATAGCTTCATAGTTTAGCCTATAGCCAACTTTGCCTCAAGACCTCCAGATAAGATGAAGTGG CTTTTACCTCATGTGAGTCTCAAACGCTGGAGAGAGAGTTCCACAACCACCCCTGCCCTTTCTCCCATATTACGCTCATTAGAAAGTCTA CTCAGGGCTGGGTGCCGTGGCTCATGCCTGTAATCCCAGCACTTTGGAGGCTGAGGCGGGTGGATCATCTGAGGTCAGGAGTTCGAGACC AGCCTGGCCAACATGGGGAAACCCTGTCTCTACTGAAAATATAAAAATTAGCCGGGCATGGTGGCGTGCACCTGTAATTCCAGCTACTCG GGAGGCTGAGGCAGGAGAATCACTTGAACCCCAGAGGCAGAGGCTACAGTGAGCCAAGATTGCACCACTGCACTCCAACCTGGGTGATAG AATAAGACTCTTGTCTCAAGGAAAGAAAAAATGTCTACTCAGTAGAGCAGTGATTGGCAAAGTGTGAGACCCCAGACCGGCAATATTGGC ATCTCCTGGAGACTTGTTTAAAATGCTGATTACTATTTTCAAGAACTTTCTACCTTCATTTTTACTTATTTTTTGTTTTCAAGGGCTCAT GGAATCAGTCTTCCATGTGACAGCTTTTTAAATATTTTAAGACAAAAACTGAGTCTTCTAATCTTAATTGTGTTCTAGCAGTAGTCATTG TAATTATAGTTATTTTTATAATTTATTTGTTTAGTGTATATCTGTCACTCTAGAATGTAGGCTCCCTGAGATAAAAACTATAATTCTTTT GATGGCAGTTACATTCCCAACTCTTAGCACAAGATCTAGGACATAGTATGAACTCAATAAATTTTTGTTGAATGAAAGAAAAATGCAAAT TTATAAGCCTTTTCAGAGACCTACTGAATCAAACTCTGAGAGTGGAGCCCAGCAATCTGTTGTAAAAGCTGTTTGAGTAATACTGTTGCA CTCTAAGCTTGAGAACCACTGCAATAGAACTAAGAGAACATTCATTTCACCTTCAGGCCTATTCTCTGACATCACTTGAAAAATCCTCTC TGCCTTCTGTAACCCTTAACCAACAACAGTGCCCTGTCCATGTAGGGGAAACTTCTGGGCTGTATTACAAGTGGGTAGGAAGGTATAAGG ATATCATAGTGGGAAGTATTGCTTAGAATGCCAGTACTTGTTTGCTGTGGAAGGTTTCTAGGAATGGATTGCTTAGTCTAAAGTAAGCAC TACCACCATCCACGTTTTCACTCAACACAGTGCCTTTTAATTGGTGACTAACATCAAAACACCTTGACAAACCGTTAAAACAGTATCAGA AACCATGTGTACATCCCTGTGCCTCTTAGATTGCTAAGTTCTGCTCTCATTCTTACTTCAAAGGACACTTTTTAAAGAATTGTTAATGCT TTTTTATAATACAAGTCATAGCCCTGTTGGCAAAAAGAAAAAAGATTCAGTGAGAAAGAAAAATCACTGATAATTCCATCATCCAGGGAG AACCACTGTTATTTAAGTATATGGCCTTCCAGACTTTTCTGTGCATTTATAGATATTTTTAATGGGATCAAAGTGTACATACTGTTTTGT AACTTTTTTTCACTCAACAATACCATGACTGTCTTGCTGTGTCAAGTATATTTCTACATCTCTTAATGGCTGCATGATATTCCATCATAT >In-frame_ENST00000525962_ENST00000370558_TCGA-CD-8530-01A_TGFBR3_chr1_92262844_-_SH3GLB1_chr1_87181407_length(amino acids)=423AA_start in transcript=62_stop in transcript=1333 MTSHYVIAIFALMSSCLATAGPEPGALCELSPVSASHPVQALMESFTVLSGCASRGTTGLPQEVHVLNLRTAGQGPGQLQREFTEEKLGQ AEKTELDAHLENLLSKAECTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCG ETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITRLL LEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TGFBR3-SH3GLB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000212355 | - | 3 | 17 | 737_751 | 82.0 | 852.0 | TGF-beta ligand |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000370399 | - | 4 | 18 | 737_751 | 82.0 | 851.0 | TGF-beta ligand |
Hgene | TGFBR3 | chr1:92262844 | chr1:87181407 | ENST00000525962 | - | 2 | 16 | 737_751 | 82.0 | 852.0 | TGF-beta ligand |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TGFBR3-SH3GLB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TGFBR3-SH3GLB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TGFBR3 | C1862932 | ANEURYSM, INTRACRANIAL BERRY, 1 (disorder) | 1 | ORPHANET |